Cited by

• The Signature Amino Acid Residue Serine 31 of HIV-1C Tat Potentiates an Activated Phenotype in Endothelial Cells.

  Menon M, Budhwar R, Shukla RN, Bankar K, Vasudevan M, Ranga U. Menon M, et al. Front Immunol. 2020 Sep 25;11:529614. doi: 10.3389/fimmu.2020.529614. eCollection 2020. Front Immunol. 2020. PMID: 33101270 Free PMC article.
• Per-pathogen virulence of HIV-1 subtypes A, C and D.

  Bouman JA, Venner CM, Walker C, Arts EJ, Regoes RR. Bouman JA, et al. Proc Biol Sci. 2023 May 10;290(1998):20222572. doi: 10.1098/rspb.2022.2572. Epub 2023 May 10. Proc Biol Sci. 2023. PMID: 37161335 Free PMC article.
• Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

  Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, Sema H, Tshimanga K, Bongo B, Delaporte E. Vidal N, et al. J Virol. 2000 Nov;74(22):10498-507. doi: 10.1128/jvi.74.22.10498-10507.2000. J Virol. 2000. PMID: 11044094 Free PMC article.
• Reviewing the history of HIV-1: spread of subtype B in the Americas.

  Junqueira DM, de Medeiros RM, Matte MC, Araújo LA, Chies JA, Ashton-Prolla P, Almeida SE. Junqueira DM, et al. PLoS One. 2011;6(11):e27489. doi: 10.1371/journal.pone.0027489. Epub 2011 Nov 23. PLoS One. 2011. PMID: 22132104 Free PMC article. Review.
• HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda.

  Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH. Kiwanuka N, et al. AIDS. 2009 Nov 27;23(18):2479-84. doi: 10.1097/QAD.0b013e328330cc08. AIDS. 2009. PMID: 19841572 Free PMC article.